Millie Shultz

Millie Shultz is an experienced leader in clinical operations with a robust background in the pharmaceutical and biotechnology sectors. Notable positions include Regional Associate Director at Takeda Shanghai Development Center, Head of Regional Clinical Trial Operations at Seattle Genetics, and Global Head of Clinical Operations at Galderma. Millie's career spans roles such as Clinical Research Associate at i3 Research and BattelleCRO, Sr. Clinical Assistant at Quintiles, and Director, Oncology Indication Lead at Merck. Academic credentials include a BS in Environmental Science and Natural Resources from Purdue University, an MSHS in Clinical Research Administration from The George Washington University, and a degree in Cancer Biology, Pharmacology, and Anatomy & Physiology from Harvard University. Millie's expertise encompasses clinical development project management and oncology operations, with a strong focus on strategic integration within clinical research frameworks.